Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

DexCom Inc (DXCM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow DexCom's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
127.05 -1.09    -0.85%
- Closed. Currency in USD ( Disclaimer )
After Hours
126.50
-0.55
-0.43%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,689,970
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 126.72 - 129.30
DexCom 127.05 -1.09 -0.85%

NASDAQ:DXCM Financials

 
A brief overview of the NASDAQ:DXCM financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of DexCom over time.

DexCom, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 921 million compared to USD 741.5 million a year ago. Net income was USD 146.4 million compared to USD 48.6 million a year ago. Basic earnings per share from continuing operations was USD 0.38 compared to USD 0.13 a year ago. Diluted earnings per share from continuing operations was USD 0.36 compared to USD 0.12 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

DXCM Income Statement

Gross margin TTM 62.82%
Operating margin TTM 17.14%
Net Profit margin TTM 16.82%
Return on Investment TTM 12.17%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 921 1034.5 975 871.3
Gross Profit 561.9 656.6 623.3 546.4
Operating Income 101.1 216.9 205.5 128.1
Net Income 146.4 256.3 120.7 115.9

DXCM Balance Sheet

Quick Ratio MRQ 2.43
Current Ratio MRQ 2.9
LT Debt to Equity MRQ 108.42%
Total Debt to Equity MRQ 115.28%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 6482.2 6264.5 6596.2 6820.7
Total Liabilities 4235.4 4195.9 4328.3 4720.3
Total Equity 2246.8 2068.6 2267.9 2100.4

DXCM Cash Flow Statement

Cash Flow/Share TTM 2.08
Revenue/Share TTM 9.86
Operating Cash Flow  13.12%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 209.2 133.6 269.2 190.3
Cash From Investing Activities 74.8 414.9 -179.5 -555.9
Cash From Financing Activities 4.7 -631.9 -637.4 939.5
Net Change in Cash 284.9 -77.3 -551.2 571.7
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DXCM Comments

Write your thoughts about DexCom Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
מאיר מאירונוביץ
מאיר מאירונוביץ Feb 11, 2024 8:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happens two days ago to DXCM?
dummey dummey
dummey dummey Oct 05, 2023 12:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good up move come TRG 86
Noah Wright
Noah Wright Apr 29, 2023 4:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
opening manufacturing in SE Asia and unlock 2 million new customers on Medicare. 23 will be a good year.
Wilson Gatan
Wilson Gatan Jul 28, 2022 7:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
-17% before eranings report hmmm insider???
Tu-Anh PHO
Tu-Anh PHO Jan 14, 2022 4:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happens yesterday 13/01/2202 TO DXCM ?
Morfe Wils
Morfe Wils Nov 15, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Breakinf anothe ATH- promising
Wilson Gatan
Wilson Gatan Oct 29, 2021 12:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
silently but keeps rising and rising....
Wilson Gatan
Wilson Gatan Sep 09, 2021 4:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dexcom more catalysts to come pls...... long term investors
Mustafa Mond
Mustafa Mond Jul 29, 2021 5:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great ernings
Shamsu Liman
Shamsu Liman Jul 29, 2021 5:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
slm
Shamsu Liman
Shamsu Liman Jul 29, 2021 5:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yaharkar takene
ganesh angaj
ganesh angaj Jun 27, 2021 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DEXCOM BUY AT 430 SL 412 TGT 455.80
ganesh angaj
ganesh angaj Jun 27, 2021 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DAY high DEX COM 445🚀🚀🚀
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email